What MTHFR Does
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that converts folate into its active form, 5-methyltetrahydrofolate (5-MTHF), which is the form that can cross the blood-brain barrier and participate in methylation. Methylation is one of the most fundamental biochemical processes in the body — it regulates DNA expression, neurotransmitter synthesis, detoxification, and dozens of other processes. Single nucleotide polymorphisms (SNPs) in the MTHFR gene — particularly the C677T variant — reduce enzyme activity by 30-70 percent, which means that people with these variants metabolise folate less efficiently.
Why This Matters for Mood and Health
The methylation cycle is directly linked to the production of mood-regulating neurotransmitters: low folate status is associated with depression, and some studies suggest that up to 40 percent of people with depression have MTHFR polymorphisms that impair folate metabolism. For these individuals, supplementing with folic acid is largely ineffective — they need the active form, 5-MTHF (also called methylfolate or levomefolic acid), which bypasses the MTHFR enzyme entirely. Methylfolate supplementation has shown efficacy in improving mood in people with depression who have MTHFR variants, even when standard antidepressants have failed.
The Methylation Cycle and Why B Vitamins Matter Together
Vitamin B12, folate (B9), and B6 are the three B vitamins most intimately involved in the methylation cycle — the core biochemical pathway that controls DNA synthesis, neurotransmitter manufacture, detoxification, and cellular energy production. The methylation cycle depends on these three vitamins working in sequence: B12 activates folate, which donates methyl groups for the conversion of homocysteine to methionine, which then goes on to support the production of SAMe (S-adenosylmethionine), the body universal universal methyl donor. When any one of these three B vitamins is deficient, the entire cycle slows down, causing elevated homocysteine, impaired neurotransmitter synthesis, fatigue, and in severe cases, neurological damage. This is why isolated B vitamin supplementation often produces modest effects — you need all three working in concert.
Why B12 Deficiency Is Epidemic
B12 deficiency is one of the most common nutritional deficiencies in adults over 40, affecting an estimated 20% of the population. The reasons are multifactorial: B12 requires intrinsic factor — a protein produced by stomach cells — for absorption in the terminal ileum, and intrinsic factor production declines with age and with proton-pump inhibitor use. Additionally, the MTHFR genetic polymorphism, present in 40-60% of the population to some degree, reduces the ability to convert folate to its active 5-MTHF form, meaning that even people with adequate dietary folate may have functional folate deficiency. Active B12 (methylcobalamin) and active folate (5-MTHF) supplements bypass these conversion problems.
Homocysteine: The Marker That Predicts Risk
Elevated homocysteine is a well-established independent risk factor for cardiovascular disease, stroke, and cognitive decline. The relationship is causal, not merely correlational — homocysteine directly damages vascular endothelium and promotes atherosclerosis. For every 5 micromol/L increase in fasting homocysteine, cardiovascular risk increases by approximately 20%. The good news is that homocysteine is highly modifiable through B vitamin supplementation — specifically B12, B6, and folate — and trials of B vitamin supplementation in people with elevated homocysteine have shown reductions in cardiovascular events and cognitive decline in older adults.
The Methylation Cycle and Why B Vitamins Matter Together
Vitamin B12, folate (B9), and B6 are the three B vitamins most intimately involved in the methylation cycle — the core biochemical pathway that controls DNA synthesis, neurotransmitter manufacture, detoxification, and cellular energy production. The methylation cycle depends on these three vitamins working in sequence: B12 activates folate, which donates methyl groups for the conversion of homocysteine to methionine, which then goes on to support the production of SAMe (S-adenosylmethionine), the body universal universal methyl donor. When any one of these three B vitamins is deficient, the entire cycle slows down, causing elevated homocysteine, impaired neurotransmitter synthesis, fatigue, and in severe cases, neurological damage. This is why isolated B vitamin supplementation often produces modest effects — you need all three working in concert.
Why B12 Deficiency Is Epidemic
B12 deficiency is one of the most common nutritional deficiencies in adults over 40, affecting an estimated 20% of the population. The reasons are multifactorial: B12 requires intrinsic factor — a protein produced by stomach cells — for absorption in the terminal ileum, and intrinsic factor production declines with age and with proton-pump inhibitor use. Additionally, the MTHFR genetic polymorphism, present in 40-60% of the population to some degree, reduces the ability to convert folate to its active 5-MTHF form, meaning that even people with adequate dietary folate may have functional folate deficiency. Active B12 (methylcobalamin) and active folate (5-MTHF) supplements bypass these conversion problems.
Homocysteine: The Marker That Predicts Risk
Elevated homocysteine is a well-established independent risk factor for cardiovascular disease, stroke, and cognitive decline. The relationship is causal, not merely correlational — homocysteine directly damages vascular endothelium and promotes atherosclerosis. For every 5 micromol/L increase in fasting homocysteine, cardiovascular risk increases by approximately 20%. The good news is that homocysteine is highly modifiable through B vitamin supplementation — specifically B12, B6, and folate — and trials of B vitamin supplementation in people with elevated homocysteine have shown reductions in cardiovascular events and cognitive decline in older adults.
A quality supplement routine can make a real difference to your results.
Leave a Reply